Copyright © 2005 Elsevier Inc. All rights reserved.
Associate editor: B.L. Roth
5-HT6 receptors: a novel target for cognitive enhancement
Available online 7 July 2005.
Abstract
Over the past decade, there has been increasing interest in the role of serotonin 6 (5-HT6) receptors in higher cognitive processes such as memory. Polymorphisms of the 5-HT6 receptor have been implicated in syndromes that affect cognition, such as schizophrenia and dementia. Manipulation of 5-HT6 receptor activity alters the transmission of several neurotransmitters important in memory: acetylcholine and glutamate, as well as dopamine, ã-aminobutyric acid (GABA), epinephrine (E), and norepinephrine (NE). Several 5-HT6 antagonists have been developed, advancing the understanding of the relationship between 5-HT6 blockade and memory consolidation in diverse learning paradigms. There is also evidence that 5-HT6 receptor activity affects anxiety behaviors and may be involved in the pathophysiology of schizophrenia. Several clinically useful atypical antipsychotics and antidepressants have 5-HT6 affinity, but recently developed selective 5-HT6 receptor antagonists may present attractive, new therapeutic options for several types of disease states.
Abbreviations: 5-HT, serotonin; 5,7-DHT, 5,7-dihydroxytryptamine; AO, antisense oligonucleotides; BDNF, brain derived growth factor; E, epinephrine; GABA, γ-aminobutyric acid; GAD, glutamic acid decarboxylase; GFP, green fluorescent protein; HSV, herpes simplex virus; LSD, lysergic acid diethylamide; MEST, maximal electroshock seizure threshold; NE, norepinephrine; NCAM, neural cell adhesion molecule; RT-PCR, reverse transcription polymerase chain reaction
Article Outline
- 1. 5-HT6 receptor neurobiology
- 1.1. Introduction
- 1.2. Genetics
- 1.3. Pharmacology
- 2. 5-HT6 interactions with other neurotransmitters
- 2.1. Acetylcholine
- 2.2. Dopamine
- 2.3. Excitatory amino acids
- 2.4. γ-Aminobutyric acid
- 2.5. Monoamines
- 3. Neurological disorders
- 3.1. Memory disorders/Alzheimer's disease
- 3.2. Anxiety/depression
- 3.3. Schizophrenia
- 3.4. Implications of 5-HT6 interactions and cognition
- 4. Conclusion
- Acknowledgements
- References






E-mail Article
Add to my Quick Links

Cited By in Scopus (56)







